PD-1 knockout engineered T cells / Chengdu MedGenCell  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PD-1 knockout engineered T cells / Chengdu MedGenCell
NCT02793856: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer

Completed
1
12
RoW
Cyclophosphamide, Cytoxan, PD-1 Knockout T Cells
Sichuan University, Chengdu MedGenCell, Co., Ltd.
Metastatic Non-small Cell Lung Cancer
08/18
03/20

Download Options